In addition, the OCI-AML3 harbors the nucleophosmin (NPM1) gene mutation type A. The NPM1 mutations are the most common genetic alteration in adult AML cases, accounting for about 30% of the total cases, contributing to the use of this cell line [98]. This evidence concerns the gene NPM1 and acute myeloid leukemia.